Fly News Breaks for May 22, 2015
NBIX
May 22, 2015 | 07:14 EDT
Piper Jaffray raised its price target for Neurocrine Biosciences to $64 following the company's investor day. Piper sees a data rich second half of 2015 and reiterates an Overweight rating on the stock.
News For NBIX From the Last 2 Days